Patience David 4
4 · TriSalus Life Sciences, Inc. · Filed Aug 29, 2025
Insider Transaction Report
Form 4
Patience David
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-08-28+248,899→ 538,899 totalExercise: $5.11→ Common Stock (248,899 underlying)
Footnotes (2)
- [F1]Represents the granting of stock options upon achieving or exceeding $75 million of revenue over any twelve (12) consecutive calendar month period ending on or before December 31, 2027. The options vest immediately upon achieving the performance requirement, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- [F2]The stock options expire on December 31, 2027 if the revenue threshold is not met.